InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: EMA1 post# 10642

Tuesday, 09/27/2016 12:25:08 PM

Tuesday, September 27, 2016 12:25:08 PM

Post# of 16885
Yes, but slowly. I don't think there are any big catalysts left this year which would provide a motivation to cover.

We know sales numbers for the 3Q won't be all that high. They are supposed to meet with the EMA in the 4Q about probuphine in the EU, but if the amount of press we've had over the Summer doesn't move the stock price, then I doubt that will. We should also get some news about Pro Neura for Parkinsons (submission of the IND?), but that will probably get a big "so-what" shrug from the market.

I'm thinking a ROW Partner deal (with an upfront payment) in the 1Q is what could push the price up a bit.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News